| Symbol | AIDX |
|---|---|
| Name | 20/20 BIOLABS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Services-Testing Laboratories |
| Address | 9430 KEY WEST AVENUE, ROCKVILLE, MD 20850 |
| Telephone | 2404536339 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001139685 |
| Description | None |
(85% Positive) 20/20 BIOLABS, INC. (AIDX) Provides Update on responsibility for illustrative purposes
Read more20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
Read more20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
Read moreNew Form DEFA14A - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-08-19 <b>AccNo:</b> 0001213900-26-091729 <b>Size:</b> 46 KB
Read moreNew Form 424B3 - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090765 <b>Size:</b> 684 KB
Read moreNew Form 424B3 - 20/20 Biolabs, Inc. <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001213900-26-090758 <b>Size:</b> 666 KB
Read more20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level
Read more20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour
Read more20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy
Read more